Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 101958054 | 10195805 | 4 | F | 20141022 | 20151218 | 20140527 | 20151231 | EXP | TW-AMGEN-TWNSP2014038754 | AMGEN | 73.00 | YR | E | F | Y | 0.00000 | 20151230 | OT | TW | TW |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 101958054 | 10195805 | 1 | PS | ENBREL | ETANERCEPT | 1 | Subcutaneous | 25 MG, PER FIVE DAYS | 103795 | 25 | MG | SOLUTION FOR INJECTION IN PRE-FILLED SYRINGE | |||||||
| 101958054 | 10195805 | 2 | SS | ENBREL | ETANERCEPT | 1 | Subcutaneous | 50 MG, EVERY 10 TO 20 DAYS | 103795 | 50 | MG | SOLUTION FOR INJECTION IN PRE-FILLED SYRINGE | |||||||
| 101958054 | 10195805 | 3 | SS | ENBREL | ETANERCEPT | 1 | Subcutaneous | 50 MG, PER TEN DAYS | 103795 | 50 | MG | SOLUTION FOR INJECTION IN PRE-FILLED SYRINGE | |||||||
| 101958054 | 10195805 | 4 | SS | ENBREL | ETANERCEPT | 1 | Unknown | UNK | 103795 | SOLUTION FOR INJECTION IN PRE-FILLED SYRINGE | |||||||||
| 101958054 | 10195805 | 5 | SS | ENBREL | ETANERCEPT | 1 | Unknown | 50 MG, AS NECESSARY | 103795 | 50 | MG | SOLUTION FOR INJECTION IN PRE-FILLED SYRINGE |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 101958054 | 10195805 | 1 | Ankylosing spondylitis |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 101958054 | 10195805 | HO |
| 101958054 | 10195805 | OT |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 101958054 | 10195805 | Abdominal pain lower | |
| 101958054 | 10195805 | Arthralgia | |
| 101958054 | 10195805 | C-reactive protein increased | |
| 101958054 | 10195805 | Intentional product misuse | |
| 101958054 | 10195805 | Joint stiffness | |
| 101958054 | 10195805 | Joint swelling | |
| 101958054 | 10195805 | Ovarian neoplasm | |
| 101958054 | 10195805 | Pain | |
| 101958054 | 10195805 | Red blood cell sedimentation rate increased |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 101958054 | 10195805 | 1 | 2012 | 201405 | 0 | |
| 101958054 | 10195805 | 2 | 201502 | 0 | ||
| 101958054 | 10195805 | 3 | 20150213 | 0 | ||
| 101958054 | 10195805 | 5 | 2015 | 20151107 | 0 |